AB Sagax
SE0005127818 Short position disclosed on April 17, 2026.
0.59% of the capital sold short
1 disclosing funds
6 disclosures on record
Funds holding AB Sagax Titelia
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Oct 2025Jan 2026Apr 2026Jul 2026
August 4, 2025 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Arrowstreet Capital Limited Partnership | 0.59% | +0.09 pt | April 17, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| April 17, 2026 | Arrowstreet Capital Limited Partnership | 0.59% | still open |
| February 18, 2026 | Arrowstreet Capital Limited Partnership | 0.69% | still open |
| February 11, 2026 | JPMorgan Asset Management (UK) Ltd | 0.50% | still open |
| September 9, 2025 | Arrowstreet Capital Limited Partnership | 0.70% | still open |
| August 27, 2025 | Arrowstreet Capital Limited Partnership | 0.60% | still open |
| August 4, 2025 | Arrowstreet Capital Limited Partnership | 0.50% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.30% of the capital sold short
- Elekta AB (publ) 10.32% of the capital sold short
- JM AB 7.01% of the capital sold short
- Embracer Group AB 5.83% of the capital sold short
- Hemnet Group AB (publ) 5.59% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Bonesupport Holding AB 5.38% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.02% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Stillfront Group AB (publ) 3.87% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
- RaySearch Laboratories AB (publ) 3.63% of the capital sold short